Cleared Traditional

K130287 - MR CONDITIONAL CUP ELECTRODE, MR CONDITIONAL WEBB ELECTRODE

K130287 is an FDA 510(k) clearance for MR CONDITIONAL CUP ELECTRODE, manufactured by Rhythmlink International, LLC. The device is a Class 2 Neurology device with product code GXY cleared through the Traditional 510(k) pathway after a 114-day FDA review.

K130287 · Rhythmlink International, LLC · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2013
Decision
114d
Days
Class 2
Risk

K130287 is an FDA 510(k) clearance for the MR CONDITIONAL CUP ELECTRODE, MR CONDITIONAL WEBB ELECTRODE. Classified as Electrode, Cutaneous (product code GXY), Class II - Special Controls.

Submitted by Rhythmlink International, LLC (Columbia, US). The FDA issued a Cleared decision on May 30, 2013 after a review of 114 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1320 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Rhythmlink International, LLC devices

FDA 510(k) Submission Details - K130287

510(k) Number K130287 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 05, 2013
Decision Date May 30, 2013
Days to Decision 114 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
35d faster than avg
Panel avg: 149d · This submission: 114d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GXY Device Classification - Class 2, Special Controls

Product Code GXY Electrode, Cutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GXY Electrode, Cutaneous

All 343
Devices cleared under the same product code (GXY) and FDA review panel - the closest regulatory comparables to K130287.
ADHESIVE ELECTRODES
K132588 · Top-Rank Health Care Equipment Co., Ltd. · Nov 2013
VALUTRODE NEUROSTIMLATION ELECTRODES
K130987 · Axelgaard Mfg. Co., Ltd. · Jul 2013
INTERX STERILE SELF-ADHESIVE DUAL ELECTRODE (ISSDE)
K130816 · Neuro Resource Group, Inc. · Jun 2013
DE48-PLUS
K123915 · Grass Technologies, an Astro-Med, Inc. Product Gro · Apr 2013
ESWALLOW USA ELECTRODE,ESWALLOW USA LEADWIRE
K113375 · Eswallow USA · Jan 2013
PMT TRUSCAN SURFACE ELECTRODE
K122376 · Pmt Corp. · Dec 2012